'STRATEGIC--DISCLOSURE'..... ..from Jan.06/12 newsrelease.."The Comapny does not intend to disclose developments with respect to the contemplated proposal or the exploration of 'strategic alternatives' unless and until its Board of
Directors has approved a specific transaction."
Isotechnika Board of Directors:
Dr. Robert Foster---steps down as Chairman Jan/12 , Still sitting ? no conlfict of interest? Focus on Phase 3 trial, which is MORE OR LESS CANCELLED as guaranteed funding agreement is TERMINATED.
Daniel Park, former Business Officer, resigns, Jan/12( Iljin rep), so that no conflict of interest is possible
Woojang Choi, Iljin legal counsel-------------Still sitting,?what? no conflict of interest?
Parkash Gowd , appointed fall 2010
Peter Wijngarrd, Current Board Chair, appointed to board Feb./11
Donald Wyatt, appointed to board as rep. for 3SBio, fall 2011 (third largest shareholder ) after former 3SBIO rep resigns
Hong-Jong Yang-past president of LG Life Sciences, Seoul, Korea. ( assuming an appointee choice of Iljin: Korea> Korea? ) conflict? Presumed / Assumed?
SO ISOTECHNIKA'S STRATEGIC FUTURE IS BEING LOOKED AFTER BY , TWO 'INDEPENDENT,
UNBIASED' BOARD MEMBERS---Prakash Gowd, Dr. Peter Wijngarrd! and a legal counsel for 3SBio who steps in
a few months before! Comforting! LETS FOCUS ON THE SCIENCE!